Table 2.
Randomized controlled trials
Principal author | Study design | Participants | Intervention |
---|---|---|---|
Hoeger20 | Prospective randomized trial over 48 wk | 38 obese women with PCOS, whose insulin failed to normalize after 4 mo on the diet | Metformin (n = 9) vs Lifestyle modification + placebo (n = 11) vs Metformin + lifestyle modification (n = 9) vs Placebo (n = 9) |
Lemay17 | Prospective randomized cross-over trial over 12 mo following 4 mo diet | 28 overweight or obese women with PCOS (23 completers) | Group A: rosiglitazone + diet for 6 mo (n = 15) Group B: oral contraceptive (EE/CPA) + diet for 6 mo (n = 13) At 6 mo, groups A and B commenced rosiglitazone + EE/CPA for further 6 mo |
Gambineri18 | Prospective randomized controlled trial over 12 mo | 80 overweight or obese women with PCOS (76 completers) | Diet + placebo (n = 19) vs Diet + metformin (n = 20) vs Diet + flutamide (n = 17) vs Diet + metformin + flutamide (n = 20) |
Note: This table provides intervention details for the three randomized controlled trials that were included in this review.
Abbreviation: PCOS, polycystic ovary syndrome.